OZEM

As of Apr, 6 2026, the sector allocation of OZEM is

• Healthcare ~100%

As of Apr, 6 2026, LLY is one of the top 10 holding in OZEM, the stock price of LLY closed at 927.06 on Monday. You can purchase it in two ways:

• Direct Stock Purchase: Open a brokerage account (e.g., Fidelity, Schwab, Robinhood, Ainvest), search for ticker LLY, and place a "Buy" order.
• ETF Exposure: By buying OZEM, you automatically own LLY. LLY typically accounts for 15.92% of the OZEM portfolio.

As of Apr, 6 2026, NVO is one of the top 10 holding in OZEM, the stock price of NVO closed at 36.67 on Monday. You can purchase it in two ways:

• Direct Stock Purchase: Open a brokerage account (e.g., Fidelity, Schwab, Robinhood, Ainvest), search for ticker NVO, and place a "Buy" order.
• ETF Exposure: By buying OZEM, you automatically own NVO. NVO typically accounts for 12.86% of the OZEM portfolio.

As of Apr, 6 2026, PFE is one of the top 10 holding in OZEM, the stock price of PFE closed at 27.83 on Monday. You can purchase it in two ways:

• Direct Stock Purchase: Open a brokerage account (e.g., Fidelity, Schwab, Robinhood, Ainvest), search for ticker PFE, and place a "Buy" order.
• ETF Exposure: By buying OZEM, you automatically own PFE. PFE typically accounts for 7.35% of the OZEM portfolio.

Yes. The regions breakdown of Roundhill Financial Inc. OZEM includes 55.99% North America, 28.99% Europe, 15.02% Asia as of Apr, 6 2026.

OZEM is a active ETF.

As of Apr, 6 2026, The 1-month fund flow of OZEM recorded a decrease of -100.90K, while the 3-month and YTD figures stand at 13.07M and 13.07M respectively.

As of Apr, 6 2026, the Top 10 holdings of OZEM typically account for 66.82% of the total fund weight.

As of Apr, 6 2026, the top holdings of OZEM include:

1. LLY (~15.92%)
2. NVO (~12.86%)
3. PFE (~7.35%)
4. VKTX (~5.41%)
5. Innovent Biologics Inc (~5.40%)
6. Ascletis Pharma Inc (~4.68%)
7. Roche Holding AG (~3.91%)
8. AZN (~3.80%)
9. AMGN (~3.77%)
10. Zealand Pharma A/S (~3.57%)

The asset class of OZEM is Equity, the focus of OZEM is Health Care, the niche of OZEM is Pharma, Biotech & Life Sciences, the strategy of OZEM is Active, the weighting scheme of OZEM is Proprietary, the selection criteria of OZEM is Proprietary.

OZEM maintains a strong market presence with 52.93M in assets under management. As of Apr, 6 2026, the fund's NAV was 31.89, trading at a discount rate -0.84% with a market price of 31.62. Investors benefit from a low expense ratio of 0.59%.

• The YTD NAV total return reached -7.08%.
• The 1-year NAV total return amounted to 40.42%.
• The 3-year NAV total return totaled -0.01%.